PROTECT

This multicentre study aims to evaluate the effect of treatment with intravenous Pentoxifylline (PTX) vs placebo, in infants born at less than 29 weeks gestation with Late onset sepsis (LOS) or Necrotizing enterocolisitis (NEC).

Proudly in partnership with